The SEC vs Ripple Lawsuit is Not Over Just Yet
The United States Securities and Exchange Commission’s (SEC) legal dispute against Ripple Labs, and individual defendants including CEO of Ripple Labs Brad Garlinghouse and co-founder Chris Larsen, continues to garner attention. On March 24, the court granted the SEC an extension to submit a discovery schedule relating to the case, marking a small victory for the American financial watchdog.
On this page
According to the defense lawyer and former U.S. federal prosecutor James Filan, who cited a text-only order from the court, “The SEC shall inform the Court of its position on whether any additional discovery is required within a week of the filing of the Individual Defendants.”
The defendants must now submit an official reply by April 8. Meanwhile, the SEC’s decision on additional discovery is due the following week on April 15, with the joint proposed scheduling order due April 22 at the latest.
These dates, however, are subject to change depending on the speed of the Ripple Lab’s answer, with Filan noting that “the date the Answer is filed starts the two-week clock running for the filing of the SEC position on discovery and the Joint Proposed Scheduling Order.”
Commenced in December 2020, the dispute has become a source of frustration for the American watchdog, Ripple Labs, and the Ripple community.
The watchdog alleges that Ripple Labs generated $1.3 billion from an unregistered security offering via Ripple‘s XRP. The company, however, refutes this allegation, stating that Ripple is not a security but an international payment method.
The SEC’s claim that Ripple is a security has been challenged time and again, including by those working at the Commission. More so since Ripple’s competitors such as Bitcoin and Ethereum have been classified by the American watchdog as currencies, not securities.
Ripple boasts of a platform that enables transactions at lightning speed. It is currently trading at $0.8409 with a market cap of over $40,464,588,960.
The content on The Coinomist is for informational purposes only and should not be interpreted as financial advice. While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, or reliability of any content. Neither we accept liability for any errors or omissions in the information provided or for any financial losses incurred as a result of relying on this information. Actions based on this content are at your own risk. Always do your own research and consult a professional. See our Terms, Privacy Policy, and Disclaimers for more details.
Articles by this author
